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ABSTRACT
Celiac disease prevalence and diagnosis have increased sub-
stantially in recent years. The current gold standard for celiac
disease confirmation is visual examination of duodenal mu-
cosal biopsies. An accurate computer-aided biopsy analysis
system using deep learning can help pathologists diagnose
celiac disease more efficiently. In this study, we trained a deep
learning model to detect celiac disease on duodenal biopsy
images. Our model uses a state-of-the-art residual convolu-
tional neural network to evaluate patches of duodenal tissue
and then aggregates those predictions for whole-slide classi-
fication. We tested the model on an independent set of 212
images and evaluated its classification results against refer-
ence standards established by pathologists. Our model iden-
tified celiac disease, normal tissue, and nonspecific duodeni-
tis with accuracies of 95.3%, 91.0%, and 89.2%, respectively.
The area under the receiver operating characteristic curve was
greater than 0.95 for all classes. We have developed an auto-
mated biopsy analysis system that achieves high performance
in detecting celiac disease on biopsy slides. Our system can
highlight areas of interest and provide preliminary classifica-
tion of duodenal biopsies prior to review by pathologists. This
technology has great potential for improving the accuracy and
efficiency of celiac disease diagnosis.
Index Terms— celiac disease, biopsy, whole-slide imag-
ing, deep learning, digital pathology
1. INTRODUCTION
Celiac disease (CD), an autoimmune disorder triggered from
the consumption of gluten, affects as much as one percent
of the population worldwide [1, 2]. Patients who are diag-
nosed with CD undergo treatment in the form of a lifelong
gluten-free diet, which requires substantial patient education,
motivation, and follow-up [3]. Recent studies have found that
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the prevalence of CD has increased dramatically in the United
States and Europe, and that undiagnosed CD was associated
with a nearly four-fold increase in risk of death [4-6]. In fact,
CD remains undiagnosed in the majority of affected people,
highlighting the need for more frequent and accurate methods
for its detection [7-9].
Celiac disease diagnosis involves serological testing of
celiac-specific antibodies, followed by microscopic exami-
nation of duodenal biopsies, which are considered the gold
standard in diagnostic confirmation of CD [10, 11]. Typically,
four to six duodenal samples are taken from the patient by
an endoscopic procedure, and these samples are visually ex-
amined by a pathologist. A confirmatory diagnosis requires
detection of histological changes associated with the dis-
ease, which are classified according to guidelines from either
Marsh [12], Marsh modified (Oberhuber) [13], or Corazza
[14]. Endoscopic findings that indicate CD include scalloped
folds with or without mosaic pattern mucosa, reduction in
the number of folds, and nodular mucosa [15]. The spectrum
of histologic changes in CD ranges from only increasing in-
traepithelial lymphocytes with preserved villous architecture
to mild villous blunting to complete villous atrophy [16].
Studies have shown that the histological diagnosis of biopsies
are subject to a significant degree of inter-observer variability
[17-20]. One potential method for improving the accuracy
of CD detection on duodenal biopsies is to apply automated
image analysis to aid pathologists. Because the prevalence
of CD is increasing, active case-finding is currently being
used to screen more patients [21, 22]. An automated biopsy
analysis system could help pathologists by filtering and pre-
populating scans, improving efficiency and turnaround-time.
Recently, a subfield in artificial intelligence known as
deep learning has produced a set of image analysis techniques
that automatically extract relevant features, transforming the
field of computer vision [23]. Deep neural networks use a
data-driven approach to learn multi-level representations of
data, allowing for comprehensive image analysis and classifi-
cation [24]. These techniques are being increasingly applied
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Fig. 1. Data flow diagram for allocating whole slides for training, development, and testing of our model. For training, patches
were generated using the sliding window algorithm to train our ResNet patch classifier. The development set was used to fine-
tune hyperparameters and thresholds of our neural network. Finally, we evaluated our model on the test set of 212 whole-slide
images with reference labels.
to medical imaging to assist radiologists and pathologists
[25]. In gastroenterology, previous studies have already used
deep neural networks to classify colorectal polyps on biopsy
and colonoscopy images [26-28], intraductal papillary muci-
nous neoplasms in MRI images [29], and diabetic retinopathy
in retinal fundus photographs [30]. For CD in particular, large
video datasets captured during endoscopies have facilitated
quantitative analysis with deep learning [31, 32]. However,
endoscopic classification is for the most part not used for
confirming the diagnosis of CD. In this study, we developed
a deep learning model that detects CD from duodenal biopsy
images, the gold standard for diagnosis. We evaluated our
model on an independent test set of 212 whole-slide images.
2. METHODS
2.1. Data Collection
To train and evaluate our model for celiac disease detection,
we collected whole-slide images from all patients who under-
went duodenal biopsies from 2016 to 2018 at the Dartmouth-
Hitchcock Medical Center (DHMC), a tertiary academic care
center in Lebanon, NH. These slides contain hematoxylin-
eosin stained formalin-fixed paraffin-embedded (FFPE) tissue
specimens and were scanned by a Leica Aperio whole-slide
scanner at 20x magnification by the Department of Pathology
and Laboratory Medicine at DHMC. In total, we collected
1230 slides from 1048 patients. We randomly partitioned
1018 of these whole-slide images from 681 patients for model
training and 212 whole-slide images from 163 patients as an
independent test set for final evaluation of our model. There
was no patient overlap for the slides in the training and test
sets.
2.2. Slide Annotation
All whole-slide images used in our study were diagnosed by
attending pathologists on gastrointestinal pathology service at
the time as either normal, celiac disease, or nonspecific duo-
denitis. Normal duodenal biopsies show preserved villous ar-
chitecture with no mucosal injury or acute or chronic inflam-
mation. Celiac disease biopsies show a spectrum of histologic
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changes as described in Marsh classification [12], including
partial to total villous atrophy with intraepithelial lympho-
cytosis, chronic inflammation and crypt regenerative hyper-
plasia. Nonspecific duodenitis includes histologic changes
including peptic duodenitis, drug induced injury, and vari-
ous other differential diagnoses of villous atrophy and acute
and chronic inflammation. These labels were parsed from the
medical record database and assigned as reference standard
for slides used during model training. The training slides were
then further split into a training set of 790 images and a devel-
opment set of 228 images. Training set slides were used for
training our neural network, while development set images
were used for hyperparameter tuning. For the independent
test set of 212 images, however, all labels were separately
reviewed and confirmed by two gastrointestinal pathologists.
Disagreements between original labels and new labels were
reviewed by a senior gastrointestinal pathologist, who deter-
mined final classifications. The class distributions and roles
in the data flow for our training, development, and test set are
shown in Figure 1.
2.3. Model Development
In recent years, research in deep learning has demonstrated
successful application of convolutional neural networks for
image classification, including medical image analysis. In
our study, we used the deep residual network (ResNet) [33],
a neural network architecture built from residual blocks.
ResNet significantly outperforms early deep learning models
such as AlexNet [34] and VGG [35], and achieved state-
of-the-art performance on the ImageNet and COCO image
recognition benchmarks [36, 37]. We implemented ResNet to
take in square patches as inputs and output a prediction prob-
ability for each of the three classes: normal, celiac disease,
and nonspecific duodenitis.
For model training, we used a sliding window method
on each high-resolution whole-slide image to generate small
patches of size 224 by 224 pixels. Since some classes had
more whole-slide images than others, we generated patches
with different overlapping areas for each class. When in-
putting a patch into the model for training, we normalized the
RGB color channels to the mean and standard deviation of
the entire training set to neutralize differences in color among
slides. Then, we performed color jittering on the brightness,
contrast, saturation, and hue of each patch. Finally, we ran-
domly rotated and flipped the images across the horizontal
and vertical axes. In total, we generated 80,000 patches for
each of our three classes, which were then uniquely aug-
mented during each epoch in training.
In terms of model parameters, we initialized ResNet-
50, the fastest ResNet with three-layer residual blocks, with
weights from the He initialization [38]. We trained our
ResNet model by optimizing on a multi-class cross-entropy
loss function for forty epochs on the augmented training set,
starting with an initial learning rate of 0.0001 and decaying
by a factor of 0.85 every epoch. We used the Adam optimizer
[39] and weight decay regularization (L2 penalty) [40] of
0.0001. Total training time was twelve hours on a Titan Xp
graphics processing unit (GPU).
2.4. Whole-Slide Inference
In whole-slide inference, we aimed to classify each whole-
slide image as either normal, celiac disease, or nonspecific
duodenitis. The model is trained to classify small patches
rather than entire slides, so we again used the sliding window
algorithm to break down each whole slide into a collection
of patches, each overlapping by one-third area. Next, we ap-
plied our trained ResNet model to classify each patch, and we
filtered out noise using thresholding to discard predictions of
low confidence. Given the distribution of patch predictions,
we used the following heuristic to determine the whole-slide
class: if more than γ patches were classified as nonspecific
duodenitis, then the whole slide was classified as nonspecific
duodenitis. Otherwise, the most commonly predicted class
was chosen as the whole-slide prediction. Thresholds for fil-
tering noise, as well as γ, were optimized by performing a
grid search over the development set. This allowed for accu-
rate classification of slides with a significant amount of non-
specific duodenitis that was not covering the majority of the
specimen area. Figure 2 depicts the whole-slide inference
process. Inference time for a single whole-slide image was
about fifteen seconds on a single Titan Xp GPU.
2.5. Evaluation and Visualization
For final evaluation, we applied our model to the independent
test set of 212 whole-slide images. We compared the pre-
dictions of our model with reference standards established by
pathologists, and measured accuracy, precision, recall, and F1
score for each class. We calculated confidence intervals for all
performance metrics using the Clopper and Pearson method
[41]. In addition, we plotted Receiver Operating Characteris-
tics (ROC) curves and calculated area under the curve (AUC)
for each class.
Furthermore, we visualized our models predictions at
both the whole-slide and patch level. At the whole-slide level,
we overlaid color-coded dots on patches for which the model
predicted a particular pattern. This helps pathologists quickly
identify regions of the slide containing abnormal tissue. At
the patch level, we used the class activation mapping (CAM)
method [42] to generate a pixel-level heat map that highlights
the most informative regions of the image relevant to the
predicted class. This demystified our classification method
for each patch by revealing the most significant histologic
features on the patch for each class for our model.
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Fig. 2. Overview of detection of celiac disease on whole-slide biopsy images. We used a sliding window approach on a
whole-slide image to generate patches, classified each patch with a ResNet model, and used a heuristic on the aggregated patch
predictions to classify the whole slide.
3. RESULTS
For model selection, we validated our neural network model
on the development set of 228 images. We found the optimal
thresholds for filtering out noise at the patch-level to be 0.7
for the normal class, 0.8 for the celiac disease class, and 0.85
for nonspecific duodenitis. For selection of the γ threshold
for percent area needed to classify a whole-slide as nonspe-
cific duodenitis, we considered our gastrointestinal patholo-
gists subjective examination of our models predictions in ad-
dition to a grid search to arrive at γ = 0.25. After threshold
optimization, our best model applied to the development set
achieved an accuracy of 95.6% for normal, 98.7% for celiac
disease, and 94.3% for nonspecific duodenitis after threshold
optimization.
Performance of our model on the independent test is
shown in Table 1, which includes accuracy, precision, recall,
and F1 score with 95% confidence intervals. Notably, our
model detects the presence of CD with an accuracy of 95.3%
and an F1 score of 93.5%. Table 2 shows the confusion ma-
trix for predicted labels versus reference labels. ROC curves
and AUC for each class are shown in Figure 3. AUC was
greater than 0.95 for all classes. Figure 4 depicts whole-slide
visualizations of twelve biopsy samples using dots to indi-
cate predicted patch labels. Finally, CAM visualizations of
individual patches are shown in Figure 5 to highlight relevant
features used in our models classification process. A sub-
jective qualitative investigation of these visualizations by a
gastrointestinal pathologist confirmed that the predictions of
our model are generally on target.
Fig. 3. ROC curves and their area under the curves (AUCs)
for our models classifications on the independent test set of
212 whole-slide biopsy images.
4. DISCUSSION
Duodenal biopsies are the gold standard for confirming the
diagnosis of CD. The prevalence of CD has increased dramat-
ically in recent years, and active case-finding calls for more
serological tests and duodenal biopsies. Detection of CD on
these biopsies could potentially be enhanced and facilitated
by automated image processing. In this study, we presented a
deep learning model that classifies duodenal tissue and high-
lights the associated features and regions of interest. Previous
4
Fig. 4. Visualization of patch predictions of our model at the whole-slide level. A-D was correctly classified as normal, E-H
was correctly classified as celiac disease, and I-L was correctly classified as nonspecific duodenitis.
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Accuracy (%) Precision (%) Recall (%) F1 Score (%)
Normal (n = 71) 91.0 (87.2-94.9) 83.3 (75.1-91.6) 91.5 (85.1-98.0) 87.2 (79.9-95.2)
Celiac Disease (n = 74) 95.3 (92.4-98.1) 90.0 (83.4-96.6) 97.3 (93.6-99.9) 93.5 (87.8-99.3)
Nonspecific Duodenitis (n = 67) 89.2 (85.0-93.3) 90.7 (83.0-98.5) 73.1 (62.5-83.7) 81.0 (71.5-90.5)
Average 87.7 (83.3-92.2) 88.0 (80.5-95.4) 87.3 (79.5-95.2) 87.2 (79.4-95.1)
Table 1. Performance of our final model for celiac disease detection on 212 duodenal biopsy whole-slide images in our test set.
95% confidence intervals are shown in parentheses.
Prediction Reference
Normal Celiac Disease Duodenitis
Normal 65 2 11
Celiac Disease 1 72 7
Duodenitis 5 0 49
Table 2. Confusion matrix of our final model for celiac dis-
ease detection on 212 duodenal biopsy whole-slide images in
our test set.
work has used deep learning to detect CD from endoscopic
images [31, 32]. While acknowledging the substantive work
of these investigators, endoscopies are for the most part not
used for confirming CD diagnoses. Our model not only de-
tects CD on duodenal biopsies, but it also visualizes regions
of normal tissue, celiac disease, and nonspecific duodenitis to
aid review by pathologists. Of note, we are not aware of any
other existing system for CD detection on biopsy images.
Our model achieved high performance for detection of
celiac disease. On the independent test set of 212 images, our
model detected CD with a considerable F1 score of 93.5% and
AUC of 0.993. Since our model made predictions at the patch
level and then aggregated them for whole-slide inference, it
was relatively unaffected by noise and achieved high accu-
racy. For normal and nonspecific duodenitis, F1 scores were
87.2% and 81.0% respectively. Identification of nonspecific
duodenitis was more challenging because this classs tissue
often also contains some normal tissue fragments, which
complicate the analysis. Sixteen slides were misclassified
between normal and nonspecific duodenitis, and pathologist
evaluation of these errors revealed errors related to tissue
orientation, fixation artifact, and patchy histologic changes.
In addition, seven slides of nonspecific duodenitis were iden-
tified as celiac disease due to focal increase of intraepithelial
lymphocytes and partial villous atrophy. Performance mea-
sures for the nonspecific duodenitis class were the lowest
across the board. There are several reasons for this. One
could be that nonspecific duodenitis had the lowest number
of training samples, comprising only 64 images in the train-
ing set compared to 620 and 106 for normal tissue and celiac
disease respectively. Another could be that this category
comprises several disease entities including peptic chronic
duodenitis, active duodenitis, and other nonspecific reactive
changes, making it more challenging to detect since there
was a wider range of histologic attributes to learn. Finally,
slides labeled as nonspecific duodenitis often contained some
portions of normal tissue, and since we extracted patch labels
based on whole-slide labels during the training process, it is
likely that some mislabeled data was used in model training
and made it harder to detect this class in our approach.
In terms of visualization, the class activation mapping
results of our models selected areas of attention indicate that
our model has learned the correct histologic features for each
class. Classification of normal tissue tended to be holistic,
with attention to almost all tissue area including normal vil-
lous architecture. For celiac disease, the model correctly
identified villous atrophy, intraepithelial lymphocytosis, and
chronic inflammation in the lamina propria. In the case of
nonspecific duodenitis, the model identified villous thicken-
ing, Brunners gland hyperplasia, foveolar metaplasia, and
chronic inflammation.
Our results indicate that deep neural networks have sub-
stantial potential to aid gastrointestinal pathologists in diag-
nosing CD. For application in a clinical setting, our model
could be integrated into existing laboratory information man-
agement systems to pre-populate patch predictions on slides
and provide preliminary diagnoses prior to review by pathol-
ogists. In addition, a visualization of the slide evaluated by
our model at the piecewise level could highlight precise tissue
area containing abnormal or sprue patterns, allowing pathol-
ogists to quickly examine regions of interest. As CD preva-
lence has increased dramatically in recent years, more sero-
logical screenings and duodenal biopsies are being done for
patients at risk [21, 22]. With biopsies as the gold standard
for diagnosis, our work aims to provide pathologists with a
tool for more accurate and efficient detection of CD.
The model presented in this paper is rooted in solid deep
learning methodology and achieves commendable perfor-
mance, but there are several limitations of our study. One
limitation is that all biopsy slides were collected from a sin-
gle medical center and scanned with the same equipment,
so our data may not be representative of the entire range
of histologic patterns in patients worldwide. Although our
whole-slide scans are high resolution and we were able to
extract a large number of patches for training with the sliding
window method, our dataset is still small in comparison to
conventional datasets in deep learning, which contain more
than ten thousand unique samples per class [43, 44] and more
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Fig. 5. Class activation mapping (CAM) heat maps highlighting most informative regions of patches relevant to normal,
celiac disease, and nonspecific duodenitis classes. Red regions indicate areas of attention for our residual neural network.
Classification of normal tissue tends to be holistic, with attention to almost all tissue area including normal villous architecture.
For celiac disease, the model correctly identified villous atrophy, intraepithelial lymphocytosis, and chronic inflammation in
the lamina propria. In the case of nonspecific duodenitis, the model identified villous thickening, Brunners gland hyperplasia,
foveolar metaplasia, and chronic inflammation.
than a million unique images in total [45, 46]. Overfitting
is unlikely because we generated a large number of small
patches for training and conducted final evaluation on an in-
dependent test set, but it is still a possibility. Collecting more
data in collaboration with another medical center in future
work would allow us to train a more generalizable neural
network and could also improve our models performance in
classifying nonspecific duodenitis.
Moving forward, more work will be done to further the
capabilities of our model and evaluate its use a clinical set-
ting. Collecting an annotated dataset with specific histopatho-
logical classifications of celiac disease and labeled bounding
boxes around lesions would allow our model to classify and
locate specific lesion types, providing pathologists with more
comprehensive slide analysis, particularly for the nonspecific
duodenitis class. Furthermore, once more data is collected,
we can predict slide level results by using patch predictions
to train a traditional machine learning classifier such as a sup-
port vector machine or random forest, which may yield better
results than our current thresholding method. In terms of clin-
ical application, we plan on validating our model on a larger
test set from multiple institutions and deploying a trial im-
plementation of our model into laboratory information man-
agement systems at the Dartmouth-Hitchcock Medical Cen-
ter to measure its ability to improve CD detection accuracy
and efficiency. However, widespread clinical implementation
of such artificial intelligence tools will require major future
steps, which our group will be undertaking. Any deep learn-
ing models for computer-aided pathology must be thoroughly
validated through clinical trials and be proven to enhance out-
comes. Such model must also not impact the established
workflow of pathologists or slow down the speed of existing
programs. Most importantly, deep learning models must be
accurate and gain the confidence of physicians, patients, and
the medical community. In its current state, artificial intelli-
gence has the ability to analyze images and make preliminary
classifications, but much more work must be done before pa-
tients and physicians will be able to trust computers to make
medical decisions. We believe the work presented in this pa-
per is a preliminary step in this direction.
In summary, we have demonstrated that deep learning can
achieve high accuracy in detecting CD in duodenal biopsies.
Our model uses a state-of-the-art residual neural network ar-
chitecture for whole-slide classification and achieved exem-
plary results on an independent test set of 212 whole-slide
images. As CD prevalence and screening increases, we ex-
pect our model could assist pathologists in more accurate and
efficient evaluation of duodenal biopsy slides.
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